Michael Dourson

Michael Leonard Dourson

Professor of Environmental Health, Risk Science Center

Professional Summary

Michael L. Dourson, Ph.D., DABT, FATS, FSRA
Professor, Risk Science Center
University of Cincinnati, College of Medicine 
 
Michael Dourson is Professor in the Risk Science Center (formerly the Toxicology Excellence for Risk Assessment Center) at the University of Cincinnati, College of Medicine.  He also founded and led the nonprofit Center’s predecessor of 21 years, also called TERA. Prior to directing TERA, he worked for 15 years in the U.S. Environmental Protection Agency in numerous leadership positions.  He has won several awards including 4 bronze medals at EPA, the Arnold J. Lehman award from the Society of Toxicology, and the International Achievement Award by the International Society of Regulatory Toxicology and Pharmacology.  He has also been elected as a Fellow of the Academy of Toxicological Sciences and as a Fellow for the Society for Risk Analysis.  Dr. Dourson has co-published more than 150 papers on risk assessment methods or chemical-specific analyses.  He has co-authored well over 100 government risk assessment documents, many of them risk assessment guidance texts.  He has made over 150 invited presentations to a variety of organizations, and has chaired over 150 sessions at scientific meetings and independent peer reviews.  He has been elected to multiple officer positions in the American Board of Toxicology (including its President), the Society of Toxicology (including the presidency of 3 specialty sections), the Society for Risk Analysis (including its Secretary), and is the President of the Toxicology Education Foundation, a nonprofit organization with a vision to help our public understand the essentials of toxicology.  In addition to numerous appointments on government panels, such as EPA’s Science Advisory Board, he is also a member on the editorial board of Regulatory Toxicology and Pharmacology, Human and Experimental Toxicology and Toxicology Sciences. 
 

Education

Ph.D. Toxicology, University of Cincinnati, College of Medicine Kettering Laboratory, 1980 (Toxicology)

B.A., Wittenberg University Springfield, Ohio, 1974 (Biology. As an undergraduate student I passed my senior exam in biology with distinction. During my education I also worked in Liberia, West Africa for 5 months with a missionary doctor on medical problems in that country and with the Peace Corps on growing experimental species of rice. In part from this experience, I decided to continue my professional education in the field of preventive medicine. )

Positions and Work Experience

1980 -1994 Various positions, _____ 1991-94 Chief. Systemic Toxicants Assessment Branch, Environmental Criteria and Assessment Office (ECAO), U.S. Environmental Protection Agency (EPA). I supervised scientists that prepared health assessment documentation and conducted risk assessment research for the EPA's Offices of Water, Solid Wastes and Air Quality Planning and Standards. _____ 1990-91 Associate Director, Environmental Criteria and Assessment Office. I directed scientific peer review, directed the development of research needs, coordinated ECAO's participation in research and development, and served as an expert in toxicology and risk assessment issues. _____ 1989-90 Chief. Pesticides and Toxics Team, Office of Technology Transfer and Regulatory Support, EPA. I supervised a group of scientists that supported the regulatory efforts of the EPA's Office of Pesticides and Toxic Substances. _____ 1986-89 Chief. Methods Evaluation and Development Staff, ECAO, EPA. I supervised a group that developed risk guidelines and EPA's Integrated Risk Information System (IRIS). I also served for two months each as a scientific advisor to the deputy administrator of EPA's Region 5, and as a scientific staffer in the policy office of the EPA's Office of Pesticide Programs. _____ 1985 Leader. Acceptable Daily Intake (ADI) Group, ECAO, EPA. I coordinated a group of scientists that developed health documentation for the EPA's interagency ADI Work Group. _____ 1984-85 Leader. Systemic Toxicant Assessment Group, ECAO, EPA. I coordinated a group of scientists that prepared health assessment documents for the EPA's Office of Water as per by Congressional legislation’s. _____ 1980-84 Staff Toxicologist, ECAO, EPA. I prepared a variety of health assessment documentation. During part of this time I also coordinated the office's efforts to develop health documentation for the EPA's Office of Solid Waste and Emergency Response as mandated by Congressional legislation., US Environmental Protection Agency, Cincinnati, Ohio

1995 -2015 Director and President, I led this nonprofit corporation in its mission to support the protection of public health by developing, reviewing and communicating risk assessment values and analyses, improving risk methods through research, and educating risk assessors and managers and the public on risk issues. TERA provided sponsors and the public with independent and objective opinions. TERA had approximately 20 staff and a budget of 3 million dollars. 1995-2008 Director of TERA. I founded and directed the scientific activity of TERA including research of new risk methods, development of risk documents, review of risk positions, and education of various groups on risk issues. Many collaborative efforts among government, industry, and environmental NGOs were established. The International Toxicity Estimates for Risk (ITER) and Alliance for Risk Assessment (ARA) were created. , Toxicology Excellence for Risk Assessment , Cincinnati, Ohio

2015 -2016 Professor and TERA Center Director, Current assignment. See previous descriptions., University of Cincinnati, College of Medicine, Cincinnati, Ohio

2017 -To Present Professor of Environmental Health, Research interests include determination of chemical critical effect and subsequent dose response assessment, Risk Science Center, University of Cincinnati, College of Medicine

Research and Practice Interests

My career to date has consisted of developing new methods for assessing potential human risk based on theoretical research, and creating risk assessment positions based on literature review and integration for hundreds of individual chemicals or mixtures.  This dual effort has resulted in over 150 peer-reviewed publications and invited presentations as enumerated (in part) on my curriculum vitae, and hundreds of government or industry risk documents available at different websites.  During this career, I have also had the pleasure of developing both scientific staff and organizations towards the vision of toxicology excellence for risk assessment.
 
Continuing my career at the University of Cincinnati’s Department of Environmental Health (DEH) would be spectacular.  Not only would the current work of Toxicology Excellence for Risk Assessment (TERA) be enhanced with the addition of scientific expertise, experience and contacts of DEH, but TERA’s work could also be parlayed by DEH to further extend its mission to improve the quality of life by identifying the mechanisms of disease and injury due to environmental exposures and genetic factors, and by developing effective methods of preventions and interventions. 
 
More specifically, TERA would assist DEH in developing or reviewing human health risk assessments to improve public health, a significant part of both organizations missions. TERA would also assist DEH in providing opinion in areas of general toxicology and health risk assessment to interested federal and state scientists, lawyers and administrators, industry colleagues, other scientists and the general public.  Numerous publications and invited presentations would follow.  All of this activity, in turn, would solidify the foundation on which a school of public health might be built.
 
I am excited about the possibilities, and look forward to the future.  On a personal note, it will be rewarding to come back to the University of Cincinnati, College of Medicine.  This would allow me to pay back, in a small way, the training I received from the College in 1975 to 1980, where my dissertation research involved the mouse lung adenoma, carcinogen bioassay, publications from which appeared in the Journal of the National Cancer Institute.

 

Research Support

Grant: #Numerous contracts, Investigators:Michael Dourson and Colleagues 1995 -2017 2/3 for Government 1/3 for Industry For a list of sponsors over 2% effort since 2010, see http://www.tera.org/about/FundingSources.html. Funding while at UC is for 2015-16 and found at http://med.uc.edu/eh/centers/rsc/about-us/funding Role:Principal Investigator over 20 million; Active Type:Contract Level:International

Grant: #862839 / FA8650-15-2-6608 Investigators:Dourson, Michael 03-01-2016 -08-30-2016 Air Force Research Laboratory TRAC 2016 Role:PI $5,000.00 Active Level:Federal

Grant: #10005681 Investigators:Dourson, Michael 03-07-2016 -12-31-2016 Electric Power Research Institute Proposal to Develop a Consistent Approach for the Peer Review Process for the Entrainment Information at 122.21(r)(10), (11) and (12) of the Final §316(b) Rule Role:PI $46,587.00 Active Level:Private Non-Profit

Grant: #HHSN276201200161P Investigators:Dourson, Michael 07-01-2015 -01-31-2017 National Library of Medicine International Toxicology Estimates for Risk (ITER) Database for use in NLM's TOXNET System Role:PI $35,000.00 Active Level:Federal

Grant: #HHSN276201700091P Investigators:Dourson, Michael 03-01-2017 -02-28-2018 National Library of Medicine International Toxicity Estimates for Risk database Role:PI $35,000.00 Awarded Level:Federal

Publications

Peer Reviewed Publications

Over 150 Publications (recent ones selected) _____Michael L. Dourson, Jeri Higginbotham, Jeff Crum, Heather Burleigh-Flayer, Patricia Nance, Norman D. Forsberg, Mark Lafranconi, John Reichard. 2017. Update: Mode of action (MOA) for liver tumors induced by oral exposure to 1,4-dioxane. Regulatory Toxicology and Pharmacology 88:45-55. _____Richard A. Becker, Vicki Dellarco, Jennifer Seed, Joel M. Kronenberg, Bette Meek, Jennifer Foreman, Christine Palermo, Chris Kirman, Igor Linkov, Rita Schoeny, Michael Dourson, Lynn H. Pottenger, and Mary K. Manibusan. 2017. Quantitative weight of evidence to assess confidence in potential modes of action. Regulatory Toxicology and Pharmacology, 86:205–220. _____Michael Dourson and Raymond G York. 2016. Advances in Assessing Ingredient Safety. Regulatory Toxicology and Pharmacology. 79:S112-S118. _____Michael Dourson, Bernard Gadagbui, Rod Thompson, Edward Pfau, and John Lowe. 2016. Managing Risks of Noncancer Health Effects at Hazardous Waste Sites: A Case Study Using the Reference Concentration (RfC) of Trichloroethylene (TCE). Regulatory Toxicology and Pharmacology. 80:125-133._____ Ted W. Simon, Yiliang Zhu, Michael L. Dourson, Nancy B. Beck. 2016. Bayesian methods for uncertainty factor application for derivation of reference values. Regulatory Toxicology and Pharmacology 80:9-24._____ Dourson, Michael, Chinkin, Lyle, MacIntosh, D.L., Finn, Jennifer, Brown, Kathleen, Reid, Stephen, Martinez, Jeanelle. 2016. A Case Study of Potential Human Health Impacts from Petroleum Coke Transfer Facilities. Journal of the Air & Waste Management Association May. DOI: 10.1080/10962247.2016.1180328._____ Nancy B. Beck, Richard A. Becker, Neeraja Erraguntla, William H. Farland, Roberta L. Grant, George Gray, Christopher Kirman, Judy S. LaKind, R. Jeffrey Lewis, Patricia Nance, Lynn H. Pottenger, Susan L. Santos, Stephanie Shirley, Ted Simon, Michael L. Dourson. 2016. Approaches for describing and communicating overall uncertainty in toxicity character .

Invited Publications

see prior publications

Additional Publications

Presentations

Invited Presentations

Over 150 Invited Presentations (recent ones selected) _____“Health risk assessment for perchlorate: New direction in EPA’s modeling approach for establishing standards” American Water Works Association. Annual Conference. Philadelphia, PA. June 14, 2017. _____“Hazard identification” “Dose response assessment” “Exposure assessment” “Risk characterization” Ateneo School of Medicine and Public Health. Makati City, Philippines. June 1-2, 2017. _____“Risk Assessor Certification” Taiwan Chapter of the Society for Risk Analysis. Taichung City, Taiwan. May 24, 2017. _____“Overview of risk assessment” “Hazard identification II: Cancer” “Dose response assessment II: Cancer” “Introduction to dose response assessment modeling” “Use of PBPK modeling in risk assessment” “Risk characterization” The Regional Training Program on Risk Assessment, Bibliotheca Alexandrina, Alexandria, Egypt, April 24-27, 2017. _____“Managing the non-cancer risks a hazardous waste sites: Trichloroethylene (TCE) as a case study” Association for Environmental Health and Sciences (AEHS) Foundation. San Diego, California March 21, 2017. _____“The concept of hormesis and application in risk assessment” Society of Toxicology, Baltimore, Maryland, March 14, 2017. _____“The concept of hormesis and application in risk assessment” Society for Risk Analysis. San Diego, California, December 12, 2016 _____“Mechanics of Risk Assessment” In workshop on Risk Analysis. Institute for Humane Studies and the Mercatus Center at George Mason University. Portland, Oregon, June 18th, 2016. _____“Yes, ‘Thresholdable’ Carcinogens Are Still Delaney Carcinogens” Roundtable Session: Is a “Thresholdable” Carcinogen Still a Delaney Carcinogen? Society of Toxicology, New Orleans, Louisiana, March 14, 2016. _____“Distinguishing between Mode and Mechanism of Action, and Some Key Events for MOA” Colloquium: Role of Mode of Action in Dose-Response Assessment for Carcinogens. Food and Drug Administration and the Society of Toxicology, College Park, Maryla .

Honors and Awards

2008 -2017 AWARDS (Selected); _____2017 Outstanding Regulatory and Safety Evaluation Paper. Given for the outstanding published paper in regulatory and safety evaluation during 2016. Regulatory and Safety Evaluation Specialty Section (RSESS). Society of Toxicology. Award was based on a group effort._____2013 Risk Communication Award. KidsChemicalSafety.org was honored with the Alliance for Chemical Safety. The risk communication award recognizes a company, organization or individual who has shown outstanding leadership in communicating about chemical risks. Award was based on a group effort. _____2013 Best Charity Award. Toxic Chemical Safety awarded for recognition as one of the ‘BEST’ charities in America. Presented upon rigorous independent review for being able to certify, document and demonstrate on an annual basis that met the highest standards of public accountability, program effectiveness, and cost effectiveness. _____2009 International Achievement Award. In recognition of his outstanding contributions nationally and internationally to the advancement of regulatory science, policy, and methodologies in risk assessment and risk management and for his distinguished and creative participation in regulatory organizations and in decisions of ultimate public health significance worldwide. International Society of Regulatory Toxicology and Pharmacology. _____2008 Outstanding Risk Assessment Paper. Given for the outstanding published paper in 2007 demonstrating an application of risk assessment. Risk Assessment Specialty Section, Society of Toxicology. Award was based on a group effort. _____2008 The Independent Charities Seal of Excellence. Given to the members of Independent Charities of America and Local Independent Charities of America that have, upon rigorous independent review, been able to certify, document, and demonstrate on an annual basis that they meet the highest standards of public accountability, program effectiveness, and cost effectiveness. These Status:Recipient

1992 -2007 AWARDS Selected continued; _____2007 Service to the Voluntary Children's Chemical Evaluation Program (VCCEP). Given for service as chair of external review panels. TERA, Cincinnati, Ohio. _____2003 Arnold J. Lehman Award. An award in recognition of major contributions to risk assessment and the regulation of chemical agents, including pharmaceuticals. Society of Toxicology. _____2002 Environmental Stewardship Award. An award issued in gratitude for serving on the C8 Assessment of Toxicity Team as a toxicologist in the development of toxicity factors and screening levels. West Virginia, Department of Environmental Protection. Award was based on a group effort. _____2000 Key Risk Award. Environmental Studies Topic. Links2Go. TERA’s International Toxicity Estimates for Risk (ITER) database won this award by being 7th most accessed environmental web site in the world. Award was based on a group effort. _____1998 Outstanding Risk Assessment Paper. Given for the outstanding published paper in risk assessment during 1997. Risk Assessment Specialty Section. Society of Toxicology. Award was based on a group effort. _____1995 In Appreciation. An award for outstanding service and scientific contribution to the Environmental Protection Agency and to United States Government. _____1994 Special Achievement. An award for noteworthy contribution as a member of the Risk Characterization Team towards an EPA-wide workshop on risk characterization. 1_____992 Bronze Medal. An award for outstanding service in the review of EPA's 503 Sludge Regulations. Award was based on a group effort. _____1992 OHEA Peer Award for Scientific Achievement. An annual peer award for scientific achievement in EPA's Office of Health and Environmental Assessment _____1992 RfD/RfC Work Group Appreciation Award. For sustained superior leadership of and scientific contributions to EPA's Reference Dose/Concentration Work Group. SOT Status:Recipient

1980 -1991 AWARDS Selected continued; _____1991 Bronze Medal. An award for outstanding service in the development of EPA's Integrated Risk Information System (IRIS). Award was based on a group effort. _____1990 Special Achievement. An EPA award for ensuring ORD's involvement in regulatory support of the Office of Pesticides and Toxic Substances. _____1988 Special Achievement. An EPA award for resolution of generic issues associated with the minimum data base needed to estimate Reference Doses (RfDs). _____1987 Special Achievement. An award for further development of the EPA's -- Integrated Risk Information System (IRIS). _____1986 Bronze Medal. An EPA award "for outstanding service in the organization and review of Risk Reference Doses (Acceptable Daily Intakes) and the science from which they are derived." Award was based on a group effort. _____1984 Tribute of Appreciation. An EPA award for the "Development of Risk Assessment Guidelines." _____1980 Bronze Medal. An EPA award recognizing "Outstanding dedication, completion of tasks and contributions to environmental protection in the development of Water Quality Criteria." Award was based on a group effort. US. EPA Status:Recipient Level:National

Post Graduate Training and Education

1988-1989 Executive Potential Program, This program, sponsored by the U.S. Office of Personnel Management, provided me a host of executive experiences. It consisted of 25 days of classes, 2 two-month developmental assignments (see a brief description under employment during 1986-89), a one-week shadow of a senior executive, 3 executive interviews and an independent study on the different motivation techniques for employee performance of 4 western countries. , U.S. Office of Personnel Management, ,work occurred in several locations

1986-1987 Zenger Miller Supervision Course, This series of 25 training sessions taught me many useful techniques for my newly acquired task of managing and leading people. , US Environmental Protection Agency, ,Cincinnati, Ohio

Professional Affiliation

1985 -2015: SCIENTIFIC SESSIONS CHAIRED OR PLANNED (Selected) _____Chair: Tox21: Current Progress, Next Steps and Exploring the Concept of a New Center of Excellence Society of Toxicology. Baltimore, Maryland. March 12, 2017. _____Co-chair: Low-Dose Non-Monotonic Responses Society of Toxicology. Baltimore, Maryland. March 14, 2017. _____Chair: Endocrine Disruption: Research, Analysis, Regulation, & Communication Society of Toxicology. New Orleans, Louisiana, March 14, 2016. _____Chair: Derived No-Effect Levels+ Big Data Toxicology Meeting Society of Toxicology. New Orleans, Louisiana. March 13, 2016. _____ Chair: Well Over 100 Risk Assessment Peer Review Meetings Since 1986, and to the present, I have chaired well over 100 scientific peer review meetings for risk assessment documents. Documents have covered a number of topics including risk assessment methods and assessments including cancer and non-cancer toxicity. These meetings have been sponsored by a number of organizations through either Toxicology Excellence for Risk Assessment’s (TERA) program of the International Toxicity Estimates for Risk (ITER) database (for examples, please see www.tera.org/peer), by EPA through its IRIS database (see www.epa.gov/iris), or by groups such as Versar. These reviews have discussed well over 400 chemicals or risk issues. _____ Moderator: Can/Should peer-reviewed publications be used to formulate regulatory policy? Society of Toxicology. San Diego, California. March 23, 2015. _____ Chair: Beyond Science and Decisions: From Problem Formulation to Dose Response Alliance for Risk Assessment. Cincinnati, Ohio. May 9-11, 2015. _____ Facilitator: Integration of Scientific Evidence to Inform Ozone Effects on Human Health. Texas Commission on Environmental Quality. Austin, Texas. April 8, 2015. _____ Chair: TTC Threshold Levels & TTC Decision Tree EFSA/WHO workshop on Threshold of Toxicological Concern (TTC). Brussels, Belgium. December 3-5, 2014. _____ Chair: Chemical Assessment Advisory Committee for Ammonia U.S. Environmental Protection Agency (EPA). Washington, D.C. July 14-16, 2014. _____ Chair: Beyond Science and Decisions: From Problem Formulation to Dose Response Alliance for Risk Assessment. Austin, Texas. May 20-22, 2014. _____ Chair: Expert Panel Review of Screening Levels for Exposure to Chemicals From the January 2014 Elk River Spill West Virginia Testing Assessment Project. Charleston, West Virginia. March 31, 2014. _____ Chair: Workshop to Assess the Modes of Action of Lung Tumors in Mice From Exposures to Styrene Ethylbenzene, and Naphthalene Styrene Information & Research Center. Cincinnati, Ohio. September 17, 2013. _____ Chair: The 39th Annual Summer Meeting of The Toxicology Forum “Melding Exposure and Toxicology Science I the 21st Century: Moving from Hazard to a Risk Based Paradigm.” The Toxicology Forum. Aspen, Colorado. July 7-11, 2013. _____ Co-chair: The 37th Annual Winter Meeting of The Toxicology Forum “Advancing Risk Assessment Approaches…in the 21st Century.” Toxicology Forum. Washington, DC. January 30-Feb. 2, 2012. _____ Rapporteur: Weight of Evidence Workshop, Session #1: “From Review to Inference” Center for Advancing Risk Assessment Science and Policy (ARASP). Washington, DC. December 4, 2012. _____ Chair: The 37th Annual Summer Meeting of The Toxicology Forum Soil Exposure: What Have We Learned and How Do We Improve Problem Formulations for Risk Assessment.” Aspen, Colorado. July 10-14, 2011. Co-Chair: Society of Toxicology Workshop Session “Determination of the Contribution of Individual Stressors in Cumulative Risk Assessments.” SOT Annual Meeting. Salt Lake City, Utah. March 6-12, 2010. Chair: Fetal and Early-Life Perchlorate Exposures and Outcomes Symposium. Perchlorate Exposures, Iodine Modulation of Effect, and Epidemiologic Associations: Implications for Risk Assessment. An Ancillary Program of the Annual Meeting of the Society of Toxicology. Se

1988 -2017: APPOINTMENTS OR ELECTIONS (Selected) _____ 2017 to… Associate Editor Toxicological Sciences _____ 2011-17 Member Science Advisory Board of the U.S. Environmental Protection Agency (EPA) _____ 2009 to… Fellow Society for Risk Analysis _____ 2007 to… Advisor African Society of Toxicological Sciences _____ 2007 to… Fellow Academy of Toxicological Sciences _____ 1999 to… Member and Vice Chair (2003) Health Advisory Board. NSF International _____ 1995 to… Member Editorial Board of the Journal “Regulatory Toxicology and Pharmacology” _____ 1994 to… Member Editorial Board of the Journal "Human and Experimental Toxicology" _____ 2016 to 2017 Secretary Board of Directors, Toxicology Forum _____ 2014 to 2017 Vice President Elect, Vice President, President Society of Toxicology's Specialty Section for Regulatory and Safety Evaluation _____ 2012 to 2017 President and Member Board of Directors, Toxicology Education Foundation _____ 2012 to 2017 Member Science Advisory Council. North American Flame Retardant Association _____ 2016 Member Joint Meeting of the Food and Agriculture Organization of the United Nations (FAO) Panel of Experts on Pesticide Residues in Food and the Environment and the World Health Organization (WHO) Core Assessment Group on Pesticide Residues (JMPR) _____ 2015 Discussant “Increasing the manganese reference value despite the growing environmental and health concerns,” International Manganese Institute, University of Ottawa, October 14. _____ 2015 Member Joint Meeting of the Food and Agriculture Organization of the United Nations (FAO) Panel of Experts on Pesticide Residues in Food and the Environment and the World Health Organization (WHO) Core Assessment Group on Pesticide Residues (JMPR). _____ 2014 to… Vice President Elect, Vice President Society of Toxicology's Specialty Section for Regulatory and Safety Evaluation. _____ 2012 to… Board of Directors Member and President Toxicology Education Foundation (TEF). _____ 2011-2014 Member, Co-Chair, Chair Membership Committee of the Society of Toxicology. _____ 2011 to… Member Science Advisory Board of the U.S. Environmental Protection Agency (EPA). _____ 2010 to… Member World Health Organization (WHO) to serve as scientific expert for the Joint FAO/WHO Expert Committee on Food Additives (JECFA). _____ 2010 to… Chair Audit Committee of the Society for Risk Analysis. _____ 2009-2011 Vice President Elect, Vice President, President Society of Toxicology's Specialty Section on Mixtures. _____ 2009 to… Fellow Society for Risk Analysis. _____ 2008 to… Member and President Council of Mt. Zion Lutheran Church. _____ 2007 to… Advisor African Society of Toxicological Sciences (ASTS). _____ 2007 to… Fellow Academy of Toxicological Sciences. _____ 1999 to… Member and Vice Chair (2003) Health Advisory Board. NSF International. _____ 1995 to… Member Editorial Board of the Journal “Regulatory Toxicology and Pharmacology.” _____ 1994 to… Member Editorial Board of the Journal "Human and Experimental Toxicology." 2010 Faculty Resource person to the Risk Assessment Summer School (RASS) in Calabar, Nigeria, sponsored by the International Union of Toxicology, May 26 to 30.2008 Participant, Essential Metals Workshop Institute of Population Health, University of Ottawa. 2008 Member Green Chemistry Initiative Science Advisory Panel, California Environmental Protection Agency, Department of Toxic Substances Control. San Francisco, CA. 2007 Lecturer Shanghai Municipal Center for Disease Control and Prevention (Shanghai CDC), National Continuing Education Training Workshop on Chemical Risk Assessment and Its Development. Shanghai, P.R. China. 2006 to 2007 Member The ECOS and DoD Sustainability Workgroup. Department of Defense, Washington, D.C. 2006 Panelist Joint meeting of the dental products panel of

Contact Information

Academic - Risk Science Center (formerly TERA Center)
160 Panzeca Way,
Ohio, 45267-0056
Phone: 513 558 7949
Fax: 513 558 7199
michael.dourson@uc.edu